Business UpdateAug 5, 2026, 07:42 AM
Cardiol Therapeutics to present at Canaccord Genuity conference
AI Summary
Cardiol Therapeutics Inc. will participate in a Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference on August 11, 2026, at 9:00 a.m. EDT in Boston, MA. A live webcast of the chat will be available on the company's investor relations website. The company is a late-stage life sciences firm focused on developing anti-inflammatory and anti-fibrotic therapies for heart disease, with lead drug candidate CardiolRx™ and CRD-38 in development.
Key Highlights
- Cardiol Therapeutics to participate in a Fireside Chat.
- Event: Canaccord Genuity's 46th Annual Growth Conference.
- Date and Time: August 11, 2026, at 9:00 a.m. EDT.
- Location: InterContinental Boston Hotel, Griffin/Robinson.
- Live webcast accessible via Cardiol's investor relations website.
- Company focuses on anti-inflammatory and anti-fibrotic therapies for heart disease.
- Lead drug candidate CardiolRx™ is in pivotal Phase III MAVERIC trial for recurrent pericarditis.
- Developing CRD-38, a novel subcutaneous formulation for inflammatory heart disease.
Price Impact
More from CRDL